Maria Monica Gramatges, M.D., Ph.D.

Professor

Email

gramatge@bcm.edu

Positions

Professor: Pediatrics-Oncology
Baylor College of Medicine
Houston, TX, US

Member: Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Co-Director, Long-Term Survivor Program: Texas Children's Cancer and Hematology Center

Associate Chief, Oncology: Texas Children's Cancer and Hematology Center

Inclusion and Equity Ambassador: Baylor College of Medicine
Houston, Texas, United States

Education

MD from The University of Texas Health Science Center at Houston: Houston, TX

Fellowship at Stanford University Medical Center: Palo Alto, CA; Pediatric Hematology and Oncology

Residency at Oregon Health and Sciences University: Portland, OR; Pediatrics

PhD from Baylor Graduate School of Biomedical Sciences: 06/2015 - Houston, Texas, United States

Certifications

Board certified in Pediatric Hematology and Oncology: American Board of Pediatrics

Honors & Awards

Childhood Cancer Survivorship Award for Excellence: American Society of Pediatric Hematology and Oncology (05/2021)

Member: American Society for Clinical Investigation (04/2022)

Websites

VIICTR Publications List

Selected Publications

Gramatges MM, Qi X, Sasa GS, Chen JJ, Bertuch AA. " A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome. " Blood. 2013 May 2; 121 (18)
Pubmed PMID: 23538340.
Rabin KR*, Gramatges MM*, Borowitz MJ, Palla SL, Shi X, Margolin JF, Zweidler-McKay PA. " Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia. " Pediatr Blood Cancer. 2012 Sep ; 59 (3)
Pubmed PMID: 22102553.
Richard MA, Lupo PJ, Morton LM, Yasui Y, Sapkota YA, Arnold MA, Aubert G, Neglia JP, Turcotte LM, Leisenring WM, Sampson JN, Chanock SJ, Hudson MM, Armstrong GT, Robison LL, Bhatia S, Gramatges MM. " Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study " PLoS One. 2020 Feb 10; 15 (2)
Pubmed PMID: 32040538.
Man TK, Aubert G, Richard MA, LeJeune W, Hariri E, Goltsova T, Gaikwad A, Chen Y, Whitton J, Leisenring WM, Arnold MA, Neglia JP, Yasui Y, Robison LL, Armstrong GT, Bhatia S, Gramatges MM. " Short NK and naïve T cell telomere length is associated with thyroid cancer in childhood cancer survivors: A report from the Childhood Cancer Survivor Study " Cancer Epidemiol Biomarkers Prev. 2021 Nov 15;
Pubmed PMID: 34782395.
Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S. " Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study " Clin Cancer Res. 2014 Feb ; 20 (4)
Pubmed PMID: 24277454.
Gerbing R, Alonzo T, Sung L, Gamis A, Meshinchi S, Plon S, Bertuch A, Gramatges MM. " Shorter remission telomere length predicts delayed neutrophil recovery after acute myeloid leukemia therapy: A report from the Children’s Oncology Group " J Clin Oncol. 2016 Nov ; 34 (31)
Pubmed PMID: 27354474.
Tomlinson CG, Sasa G, Aubert G, Martin-Giacalone B, Plon SE, Bryan TM, Bertuch AA, Gramatges MM. " Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome " Leukemia. 2020 Apr ; 35 (1)
Pubmed PMID: 32313107.
Gramatges MM, Morton LM, Yasui Y, Arnold MA, Neglia JP, Leisenring WM, Machiela MJ, Dagnall CL, Chanock SJ, Armstrong GT, Robison LL, Bhatia S, Lupo PJ. " Telomere length-associated genetic variants and the risk of thyroid cancer in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study " Cancer Epidemiol Biomarkers Prev. 2019 Feb ; 28 (2)
Pubmed PMID: 30377209.
King JE, O’Connor MC, Shohet E, Krause SM, Scheurer ME, Horowitz ME, Poplack DG, Fordis CM, Gramatges MM. " Clinician perceptions of Passport for Care, a web-based clinical decision support tool for survivorship care plan delivery " Pediatr Blood Cancer. 2023 Jan ; 70 (1)
Pubmed PMID: 36326111.

Funding

Survivorship and Access to care for Latinos to Understand and address Disparities (SALUD) #UG3 CA260607: (05/10/2021 - 04/30/2023); Grant funding from NIH/NCI

(PQB-1) Telomere maintenance defects associated with thyroid second cancers in childhood cancer survivors #R01 CA194473: (07/01/2015 - 06/30/2021); Grant funding from NIH/NCI

Survivorship and Access to care for Latinos to Understand and address Disparities (SALUD) #UH3 CA260607: (05/01/2023 - 04/30/2027); Grant funding from NIH/NCI

Chronic Health Conditions in Survivors of Down Syndrome-Associated Acute Leukemia #R01 CA263000: (06/15/2022 - 06/14/2027); Grant funding from NIH/NCI

Leveraging Passport for Care to Reduce Childhood Cancer Survivorship Outcome Disparities in the Rio Grande Valley #PP220017: (03/01/2022 - 02/28/2025); Grant funding from CPRIT

Languages

Spanish